JSP 545 (Digoxin 250 mcg (0.25 mg))
Pill imprint JSP 545 has been identified as Digoxin 250 mcg (0.25 mg).
Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- JSP 545
- Strength:
- 250 mcg (0.25 mg)
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Group V antiarrhythmics
Inotropic agents - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1325
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
stearic acid
| NDC Code | Manufacturer / Repackager |
|---|---|
| 62584-0990 | Amerisource Health Services |
| 66336-0607 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about digoxin
Consumer resources
- Digoxin
- Digoxin solution
- Digoxin tablets
- Digoxin (Advanced Reading)
- Digoxin Intravenous (Advanced Reading)
- Other brands: Lanoxin, Digox, Digitek, Lanoxicaps
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
